But that $300M-500M is for a start-up to bring a product to the market from years of development to clinical trials and then commercialisation.....AVR has already done most of this, hence they 100s of millions of CR.
New AVR detailed research report with valuations, page-54
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.09 |
Change
0.580(4.29%) |
Mkt cap ! $289.5M | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.09 | $13.35 | $225.9K | 16.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 112 | $13.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.18 | 75 | 1 |
View Market Depth
| Last trade - 12.06pm 09/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |